Stryker saw year-over-year revenue growth in the second quarter of 2025, according to financial results posted July 31.
Six things to know:
1. Quarterly revenue reached $6 billion, an 11.1% increase year over year.
2. Orthopedic sales grew 2% year over year to $2.2 billion, and med-surg and neurotechnology sales grew 17.3% to $3.8 billion.
3. Hip sales increased 8.9% year over year to $466 million, and knees grew 6.3% to $640 million.
4. Spine implant sales were $5 million. In the first quarter Stryker completed the sale of its U.S. spine business to Viscogliosi Brothers.
5. Stryker operated with net earnings of $884 million. That’s an increase of 7.2% year over year.
6. For the first half of 2025 Stryker made $11.9 billion, an increase of 11.5% compared to the same period in 2024.
